| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/25/2004 | EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/25/2004 | EP1037607B1 Novel suppository form comprising an acid-labile active compound |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | EP0981620B1 Hgf polypeptides and their use in therapy |
| 02/25/2004 | EP0965344B1 Prophylactic and therapeutic agent for inflammatory intestinal diseases |
| 02/25/2004 | EP0883405B1 Amidino protease inhibitors |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478086A Process for crystallization of(R)-or(S)-lansoprazole |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1478081A Substituted 2-znilino-benzimidazoles and use thereof as NHE-inhibitors |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1478077A Benzamide compounds as APOB secretion inhibitors |
| 02/25/2004 | CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/25/2004 | CN1478067A O-substituted 6-methyl-tramadol derivatives |
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/25/2004 | CN1477967A Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 02/25/2004 | CN1477961A Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1477957A Tanshinone compound containing dihydrofuran ring structure for curing hyperammonemia and hepatic encephalopathy |
| 02/25/2004 | CN1477956A Crytotanshinone for preventing and delaying early senile dementia |
| 02/25/2004 | CN1477950A Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of critically ill, chronically ill and people with malnutrition |
| 02/25/2004 | CN1476885A Nianmoyankuiling for curing mucositis mucitis and its preparation |
| 02/25/2004 | CN1476881A Compound Chinese medicine for curing hepatic disease |
| 02/25/2004 | CN1476880A Method for extracting chimonanthus nitens oil clathrate as raw material for preparing medince for curing diseases of digestive system |
| 02/25/2004 | CN1476879A Chinese medicine for curing diarrhea and its preparation method |
| 02/25/2004 | CN1476876A Medicine for curing chronic hepatitis and hepatcirrhosis |
| 02/25/2004 | CN1476875A Chinese herbal medicine mixture for preparing medicine with functions of expelling intestinal worms, removing food stagnancy and promoting digestion for domestic animals |
| 02/25/2004 | CN1476873A Medicine composition for curing diarrhea |
| 02/25/2004 | CN1476871A (Quick-acting) lijinxiao |
| 02/25/2004 | CN1476870A Xieding capsule raw matsrial formula and its preparation process |
| 02/25/2004 | CN1476869A Production process of bianbishu capsule for curing constipation |
| 02/25/2004 | CN1476863A Haigou shenlong pill |
| 02/25/2004 | CN1476859A Bone-strengthening kidney-supplementing pill |
| 02/25/2004 | CN1476858A Chinese medicine for curing gastropathy and enteropathy |
| 02/25/2004 | CN1476857A Preparation method of medicine for curing gastropathy and treating trauma |
| 02/25/2004 | CN1476849A Medicine composition for promoting blood circulation and removing stasis |
| 02/25/2004 | CN1476846A Medicine for preventing and curing diseases and prolonging life and its method |
| 02/25/2004 | CN1476842A Fleabane extract and dicaffeoylquinic acid medicine composition and its application |
| 02/25/2004 | CN1476839A Gardenia total glycoside composite for curing hepatitis and its preparation method |
| 02/25/2004 | CN1476837A Medicine composition |
| 02/25/2004 | CN1476834A Metaduocine freeze-dried powder injection preparation and its preparation method |
| 02/25/2004 | CN1476831A Biphenyl double-ester solid slowly-releasing composite |
| 02/25/2004 | CN1139657C Coated microgranules for stabilizing lactic acid bacteria |
| 02/25/2004 | CN1139570C Inhibition of matrix metalloproteases by acetylene-containing compound |
| 02/25/2004 | CN1139399C Chinese Medicine pill for treating hepatitis B and its preparing method |
| 02/25/2004 | CN1139396C Life essence-filling marrow-benefitting and kedney-invigorating Chinese medicine preparation |
| 02/25/2004 | CN1139395C Vital energy benefitting methol powder as Chinese medicine preparation for treating gastrosis |
| 02/25/2004 | CN1139390C Method for preparing health-care medicine |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696566 Selective p38 kinase inhibitors relative to cyclin-dependent kinases and tyrosine kinases |
| 02/24/2004 | US6696491 Cetyl myristate optionally with cetyl palmitate |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/24/2004 | US6696468 (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| 02/24/2004 | US6696467 Quinoline derivatives |
| 02/24/2004 | US6696464 Triazolo-pyridines anti-inflammatory compounds |
| 02/24/2004 | US6696461 Tricyclic imidazopyridines |
| 02/24/2004 | US6696460 Prevention and treatment of gastrointestinal diseases |
| 02/24/2004 | US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom |
| 02/24/2004 | US6696457 Morphinoid compounds |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696451 Dihydropyrimidines |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696447 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 02/24/2004 | US6696446 Benzoylpyridazines, their preparation and use |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696427 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 02/24/2004 | US6696408 Administering glycosylated polypeptides as antiepileptics and anticonvulsants or for prophylaxis of psychological disorders |
| 02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 02/24/2004 | CA2219081C Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/24/2004 | CA2013518C Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them |
| 02/21/2004 | CA2437664A1 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 02/19/2004 | WO2004014956A1 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 02/19/2004 | WO2004014920A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | WO2004014911A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014905A1 Substituted benzimidazole compounds |
| 02/19/2004 | WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 02/19/2004 | WO2004014880A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014873A1 4-substituted quinazoline-8-carboxyamide derivative and pharmaceutically acceptable addition salt thereof |
| 02/19/2004 | WO2004014861A1 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof |
| 02/19/2004 | WO2004014859A2 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | WO2004014856A1 2,3-dihydro-isoindol-1-ones with mao-b inhibiting activity |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | WO2004014428A1 Remedy for intestinal diseases and visceral pain |
| 02/19/2004 | WO2004014415A1 Growth hormone releasing peptides |
| 02/19/2004 | WO2004014405A1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 02/19/2004 | WO2004014387A1 COMBINATION THERAPY WITH p38 MAP KINASE INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS |
| 02/19/2004 | WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | WO2004014310A2 Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
| 02/19/2004 | WO2004014295A2 Tiacumicin production |
| 02/19/2004 | WO2004014289A2 Use of beta-cyclodextrin (cas rn: 7585-39-9) in the preparation of medicaments for the treatment of human and animal diseases caused by cryptosporidium parasites |
| 02/19/2004 | WO2004014159A1 Method of lowering glycaemic index of foods |
| 02/19/2004 | WO2004014150A1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |